76-94-8Relevant articles and documents
Preparation method of 5-methyl-5-phenylbarbituric acid
-
Paragraph 0015-0024, (2019/07/29)
The invention provides a preparation method of 5-methyl-5-phenylbarbituric acid. The method comprises the following two steps: A, performing a reaction on diethyl alpha-methyl-alpha-phenylpropanedioate (referred to a compound III) and urea in the presence of a methanol solution of sodium methoxide to prepare sodium 5-methyl-5-phenyl barbiturate (referred to a compound II); and performing acidification on the compound (II) by using hydrochloric acid to obtain a crude product of the compound (I); and B, performing recrystallization on the crude product of the compound (I) obtained in the step Ain an ethanol aqueous solution to obtain a fine product of the compound (I). According to the preparation method provided by the invention, the reaction conditions are easy to control, the product quality is stable, the obtained crude product has a content of 99.0% or more by HPLC, and after primary purification, the purity of the product by the HPLC is >99.8%; and the production costs are low, and the method is more suitable for industrial production.
Novel 5,5-disubstitutedpyrimidine-2,4,6-triones as selective MMP inhibitors
Foley, Louise H,Palermo, Robert,Dunten, Pete,Wang, Ping
, p. 969 - 972 (2007/10/03)
The 5,5-disubstitutedpyrimidine-2,4,6-triones represent a new class of MMP inhibitors showing selectivity for the gelatinases A and B, collagenase-3, and human neutrophil collagenase. The SAR presented here is in good agreement with an X-ray structure of compound 5 bound to the catalytic domain of stromelysin-1. While of the barbiturate structural class, compound 5 did not show any toxic or sedative effects.